Soleno Therapeutics, Inc.

Why Work at Soleno? At Soleno Therapeutics, we don’t just develop treatments - we build hope. Our team is united by a shared commitment to improving the lives of those with Prader-Willi syndrome. Here’s what sets us apart: ✅ Mission-Driven Work – Every team member is contributing to our mission. ✅ Collaborative Culture – We work together to solve complex challenges. ✅ Commitment to Growth – Professional development is a priority. Want to be part of our impact? Explore opportunities here: https://bit.ly/4iyQHDE #PWSAwareness #RareDisease #Support4PWS

Soleno will be at AMCP to share insights on the substantial burden of Prader-Willi syndrome on those living with the condition and the US healthcare system. Raj Gandhi, PharmD, MBA, Director, Medical Managed Markets & HEOR, will be presenting at the AMCP 2025 Meeting being held March 31-April 3 in Houston, Texas. This analysis aims to describe key healthcare services that drive the economic burden of PWS by examining the frequency of ambulance and palliative services. #AMCP #PraderWilliSyndrome C-US-PWS-00112 v1 3/2025

Today, we announced that the FDA approved VYKAT™ XR (diazoxide choline) extended-release tablets for the treatment of hyperphagia in individuals aged 4 and older with Prader-Willi syndrome (PWS). We can proudly say that VYKAT XR is the first and only FDA-approved medicine to address hyperphagia, one of the most challenging aspects of PWS. “The approval of VYKAT XR is a significant milestone for Soleno and, most importantly, for the PWS community who have had no options to treat the most disruptive aspect of this disease,” said Anish Bhatnagar, M.D., Chief Executive Officer of Soleno. “We are deeply grateful to the many individuals with PWS, their caregivers and clinical sites who participated in our trials, the advocacy groups, including FPWR and PWSA USA, the advocates who have tirelessly supported the approval of VYKAT XR, the FDA for a collaborative review process, and our employees who have been committed to delivering VYKAT XR to those with PWS.” Read the full press release: https://lnkd.in/giM_gTav #FDAApproval #PWS #PraderWilliSyndrome #Soleno

In this video, John’s family shares their emotional journey as they navigate his transition to a group residential home. Lynn, his mother, and Hannah, John’s sister, open up about the challenges of finding the right support for John's unique needs and how a structured environment has helped him excel. This heartfelt testimonial underscores the importance of community-based care. Watch the full video: https://bit.ly/3DSBKNe #PraderWilliSyndrome #DisabilitySupport #CommunityCare #ResidentialHomes #GroupHomes #Inclusion #PWS C-US-PWS-00111

We’re proud to foster a supportive environment that creates empowering environments and high-performing teams. "I believe that a company is only as strong as its people, and that's why I'm so committed to doing my part to foster a collaborative and high-performing environment at Soleno. Building a best-in-class team is not just a goal; it's a continuous journey, and I'm excited to be a part of it." - Raj Gandhi Learn more about careers at Soleno. https://bit.ly/4iyQHDE #PWSAwareness #Support4PWS

Prader-Willi syndrome is a rare genetic disorder, and one of its primary features is hyperphagia, an insatiable hunger that never goes away. This constant hunger can lead to serious health risks, impacting both the patient and their families. Caregivers often implement structured meals and lock away food to ensure safety. Understanding hyperphagia helps create a more informed, supportive community. Like and share this post to spread awareness! #PWSAwareness #RareDisease #Support4PWS

At Soleno, our work is more than a job, it’s a shared commitment to making a difference for individuals living with #rarediseases, starting with Prader-Willi syndrome. Every day, our team collaborates, innovates, and pushes boundaries to help make an impact. Learn more about careers at Soleno. https://bit.ly/4iyQHDE #PWSAwareness #RareDisease #Support4PWS

Stay connected and speak up about Prader-Willi syndrome (PWS). Every voice helps raise awareness and strengthen our PWS community. Sign up to receive information from Soleno Therapeutics: https://bit.ly/439USka

Hyperphagia, a primary feature of Prader-Willi syndrome, is defined by relentless hunger and it doesn’t just affect the individual; it affects the entire family. Parents constantly secure food and monitor meals, while siblings adapt to locked kitchens and strict routines. The stress is constant, and the emotional toll is heavy. Understanding hyperphagia is key to supporting those affected by PWS. Learn more at https://bit.ly/4ajzWsn #PWSAwareness #RareDisease #Support4PWS

Every journey with #PraderWilliSyndrome is unique, whether you’re living with PWS, a caregiver, or someone affected, your story matters. Share your PWS story at https://bit.ly/3V7DfNd. #PWSAwareness #RareDisease #Support4PWS #MyPWSstory